Rankings
▼
Calendar
CRMD Q2 2024 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$536M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$806,119
Gross Profit
$296,280
36.8% margin
Operating Income
-$15M
-1898.1% margin
Net Income
-$14M
-1755.5% margin
EPS (Diluted)
$-0.25
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$58M
Total Liabilities
$12M
Stockholders' Equity
$46M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$806,119
$0
—
Gross Profit
$296,280
-$50,748
+683.8%
Operating Income
-$15M
-$12M
-29.6%
Net Income
-$14M
-$11M
-25.5%
← FY 2024
All Quarters
Q3 2024 →